Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
D
023910
vs
K
KOSPI 200
Over the past 12 months, DaehanPharmaceutical has underperformed KOSPI 200, delivering a return of -13% compared to KOSPI 200's +125% growth.
Stocks Performance
023910 vs KOSPI 200
Performance Gap
023910 vs KOSPI 200
Performance By Year
023910 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
DaehanPharmaceutical
Glance View
DaehanPharmaceutical is a South Korean drug maker that develops and sells medicines for common health needs. Its products include prescription drugs, over-the-counter treatments, and related health products that are sold through hospitals, clinics, pharmacies, and other medical distributors. It also supplies ingredients and finished products that fit into the wider pharmaceutical supply chain. The company makes money by manufacturing these products and selling them to healthcare channels and distributors, with some products reaching consumers through pharmacy and retail sales. Its business depends on steady demand for everyday medicines, long-term treatment drugs, and health-support products rather than one-off projects. That makes it more of a volume-based manufacturer than a service company. What sets the business apart is its role as a practical supplier in the Korean healthcare market. Instead of focusing on a single blockbuster drug, it serves a broad mix of routine medical and wellness needs, which can help it stay relevant across different parts of the medicine market. Its value comes from making and distributing products that doctors, pharmacists, and consumers use repeatedly.